Effects of radiation on incidence of primary liver cancer among atomic bomb survivors

Radiation Research

Volumn 152, Issue 4, 1999, Pages 364-373

  Cologne, John B ^a   Tokuoka, Shoji ^a   Beebe, Gilbert W ^b   Fukuhara, Toshiyuki ^c   Mabuchi, Kiyohiko ^a  

^a RADIATION EFFECTS RESEARCH FOUNDATION   (Japan)

^b NATIONAL CANCER INSTITUTE   (United States)

^c HIROSHIMA PREFECTURAL HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ANGIOSARCOMA; ARTICLE; ATOMIC BOMB SURVIVOR; BILE DUCT CARCINOMA; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER RISK; FEMALE; HUMAN; JAPAN; LIVER CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION HAZARD; SEX RATIO; STATISTICAL ANALYSIS;

COHORT STUDIES; DEATH CERTIFICATES; FEMALE; HUMANS; INCIDENCE; JAPAN; LIVER NEOPLASMS; MALE; NEOPLASMS, RADIATION-INDUCED; NUCLEAR WARFARE; SURVIVORS;

EID: 0032862256     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.2307/3580221     Document Type: Article

References (29)

1. D. E. Thompson, K. Mabuchi, E. Ron, M. Soda, M. Tokunaga, S. Ochikubo, S. Sugimoto, T. Ikeda, M. Terasaki and D. L. Preston, Cancer incidence in atomic bomb survivors. Part II: Solid tumors, 1958-1987. Radiat. Res. 137 (Suppl.), S17-S67 (1994).
2. K. Okuda, I. Fujimoto, A. Hanai and Y. Urano, Changing incidence of hepatocellular carcinoma in Japan. Cancer Res. 47, 4967-4972 (1987).
3. M. Andersson, B. Carstensen and H. H. Storm, Mortality and cancer incidence after cerebral arteriography with or without Thorotrast. Radiat. Res. 142, 305-320 (1995).
4. T. Mori, Y. Kato, T. Kumatori, T. Maruyama and S. Hatakeyama, Epidemiological follow-up study of Japanese Thorotrast cases -1980. Health Phys. 44 (Suppl. 1), 261-272 (1983).
5. G. van Kaick, D. Lieberman, D. Lorenz, W. J. Lorenz, H. Lührs, E. Sheer, H. Wesch, H. Muth, A. Kaul and G. Wagner, Recent results of the German Thorotrast study - epidemiological results and dose effect relationships in Thorotrast patients. Health Phys. 44 (Suppl. 1), 299-306 (1983).
6. M. Andersson, Long-term effects of internally deposited α-particle emitting radionuclides. Danish Med. Bull. 44, 169-190 (1997).
7. G. van Kaick, H. Wesch, H. Lührs, D. Liebermann, A. Kaul and H. Muth, The German Thorotrast study - report on 20 years follow-up. In. Risks from Radium and Thorotrast (D. M. Taylor, C. W. Mays, G. B. Gerber and R. G. Thomas, Eds.), pp. 98-104. Report 21, British Institute of Radiology, London, 1989.
8. P. J. Baxter, A. O. Langlands, P. P. Anthony, R. N. M. Macsween and P. J. Scheuer, Angiosarcoma of the liver: A marker tumour for the late effects of Thorotrast in Great Britain. Br. J. Cancer 41, 446-453 (1980).
9. W. M. Schreiber, H. Kato and J. D. Robertson, Primary carcinoma of the liver, Hiroshima-Nagasaki, 1961-67. Cancer 26, 69-75 (1970).
10. M. Asano, H. Kato, K. Yoshimoto, S. Seyama, H. Itakura, T. Hamada and S. Ijima, Primary liver carcinoma and liver cirrhosis in atomic bomb survivors, Hiroshima and Nagasaki, 1961-75, with special reference to hepatitis B surface antigen. J. Natl. Cancer Inst. 69, 1221-1227 (1982).
11. H. Kato, Cancer mortality. In Cancer in Atomic Bomb Survivors (I. Shigematsu and A. Kagan, Eds.). Gann Monograph on Cancer Research No. 32, Japan Scientific Societies Press, Tokyo, 1986.
12. D. L. Preston, H. Kato, K. J. Kopecky and S. Fujita, Studies of the mortality of A-bomb survivors. 8. Cancer mortality, 1950-1982. Radiat. Res. 111, 151-178 (1987).
13. Y. Shimizu, H. Kato and W. J. Schull, Life Span Study Report 11. Part 2. Cancer mortality in the years 1950-85 based on the recently revised doses (DS86). Radiat. Res. 121, 120-141 (1990).
14. C. Percy, L. G. Ries and V. D. Van Holten, The accuracy of liver cancer as the underlying cause on death certificates. Public Health Rep. 105, 361-367 (1990).
15. D. A. Pierce, Y. Shimizu, D. L. Preston, M. Vaeth and K. Mabuchi, Studies of the mortality of atomic bomb survivors. Report 12, Part I. Cancer: 1950-1990. Radiat. Res. 146, 1-27 (1996).
16. E. L. Frome and H. Checkoway, Use of Poisson regression models in estimating incidence rates and ratios. Am. J. Epidemiol. 121, 309-323 (1985).
17. C. R. Muirhead and S. C. Darby, Modelling the relative and absolute risks of radiation-induced cancers. J. R. Stat. Soc. Ser. A 150, 83-118 (1987).
18. N. E. Breslow and N. E. Day, Statistical Methods in Cancer Research. Volume II - The Design and Analysis of Cohort Studies. IARC, Lyon, 1987.
19. W. C. Roesch, Ed., US-Japan Joint Reassessment of Atomic Bomb Radiation Dosimetry in Hiroshima and Nagasaki: Final Report. Radiation Effects Research Foundation, Hiroshima, 1987.
20. D. A. Pierce, D. O. Stram and M. Vaeth, Allowing for random errors in radiation exposure estimates for the atomic bomb survivors data. Radiat. Res. 123, 275-284 (1990).
21. D. A. Pierce and D. L. Preston, Joint analysis of site-specific cancer risks for the atomic bomb survivors. Radiat. Res. 134, 134-142 (1993).
22. 50 associated with exposure to the atomic bombing of Hiroshima. J. Radiat. Res. 30, 359-381 (1989).
23. F. A. Mettler and A. C. Upton, Medical Effects of Ionizing Radiation, 2nd ed. W. B. Saunders, Philadelphia, 1995.
24. Y. Shimizu, D. A. Pierce, D. L. Preston and K. Mabuchi, Studies of the mortality of atomic bomb survivors. Report 12, Part II. Noncancer mortality: 1950-1990. Radiat. Res. in press.
25. K. Neriishi, S. Akiba, T. Amano, T. Ogino and K. Kodama, Prevalence of hepatitis B surface antigen, hepatitis B e antigen and antibody, and antigen subtypes in atomic bomb survivors. Radiat. Res. 144, 215-221 (1995).
26. M. W. Yu and C. J. Chen, Elevated serum testosterone levels and risk of hepatocellular carcinoma. Cancer Res. 53, 790-794 (1993).
27. C. M. Goodall and W. H. Butler, Aflatoxin carcinogenesis: Inhibition of liver cancer induction in hypophysectomized rats. Int. J. Cancer 4, 422-429 (1969).
28. 226Ra. Health Phys. 76, 50-56 (1999).
29. S. A. Benjamin, A. C. Lee, G. M. Angleton, W. J. Saunders, T. J. Keefe and C. H. Mallinckrodt, Mortality in beagles irradiated during prenatal and postnatal development. II. Contribution of benign and malignant neoplasia. Radiat. Res. 150, 330-348 (1998).